What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2025-05-13 compared with 2024-11-08 · 53 added, 45 removed, 8 unchanged (92% of the section changed)

Other Information

and Financial Statement Schedules.

of Incorporation, as amended and as currently in effect.

and Restated Bylaws.

of Specimen stock certificate evidencing shares of common stock.

Agreement between the Company and Continental Stock Transfer and Trust company as warrant agent dated as of September 16, 2022

of Warrant Certificate (filed as part of Exhibit 4.2)

Venture Agreement between the Company and Wider Come Limited dated as of May 31, 2023.

Agreement between the Company and Mark White dated as of July 1, 2023.

Agreement between the Company and David Owens, M.D.

Underwriting Agreement dated as of September 15, 2022 between the Company and Maxim Group LLC

Equity Distribution Agreement between the Company and Maxim Group LLC

Underwriting Agreement dated May 4, 2025 between the Company and Maxim Group LLC

Certificate of Incorporation, as amended and as currently in effect.

Amended and Restated Bylaws

Form of Specimen stock certificate evidencing shares of common stock

Warrant Agreement between the Company and Continental Stock Transfer and Trust company as warrant agent dated as of September 16, 2022

Form of Warrant Certificate (filed as part of Exhibit 4.2)

Joint Venture Agreement between the Company and Wider Come Limited dated as of May 31, 2023.

Employment Agreement between the Company and Mark White dated as of July 1, 2023.

Services Agreement between the Company and David Owens, M.D.

dated as of July 1, 2023.

Assurance Agreement between the Company and Apical Instruments dated December 31, 2020.

Agreement with Leonard Osser dated as of December 22,2021.

Agreement with Tucker Anderson dated as of December 24, 2021.

Agreement with Gian Domenico Trombetta dated December 24, 2021.

Agreement between the Company and Marilyn Elson dated as of January 11, 2022

and Deferral Agreement dated as of March 30, 2022 to Consulting Agreement between the Company and US Asian Consulting Group

Agreement between the Company and Michael Nketiah dated as of July 1, 2023.

of Lock-Up Agreement.

Agreement dated as of May 9, 2018 as amended between the Company and US Asian Consulting Group, LLC, as amended on January 2,

2019 and March 4, 2021

and Restated Promissory Note in favor of Mark White dated as of January 1, 2023.

Authorization Agreement dated as of May 1, 2019 with Wider Come Limited.

Quality Assurance Agreement between the Company and Apical Instruments dated December 31, 2020.

Advisor Agreement with Leonard Osser dated as of December 22,2021

Advisor Agreement with Tucker Anderson dated as of December 24, 2021

Advisor Agreement with Gian Domenico Trombetta dated December 24, 2021

Employment Agreement between the Company and Marilyn Elson dated as of January 11, 2022

Amendment and Deferral Agreement dated as of March 30, 2022 to Consulting Agreement between the Company and US Asian Consulting Group LLC

Employment Agreement between the Company and Michael Nketiah dated as of July 1, 2023.

Form of Lock-Up Agreement.

Consulting Agreement dated as of May 9, 2018 between the Company and US Asian Consulting Group, LLC, as amended on January 2, 1019 and March 4, 2021

Amended and Restated Promissory Note in favor Mark White dated as of January 1, 2023

Distribution Authorization Agreement dated as of May 1, 2019 with Wider Come Limited.

Form of Lock-Up Agreement

Form of Securities Purchase Agreement

Agency Agreement

Placement Agency Agreement

Letter Agreement between the Company and Carolyn Shelton

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.

Certification of the Chief Executive Officer pursuant to 18 U.S.C.

Supplier Quality Agreement dated as of December 20, 2024 between the Company and Velentium

Nexalin Technology, Inc.

Insider Trading Policy

Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended

Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Committee Charter

and Corporate Governance Committee Charter

Previously filed as an

exhibit to Form S-1 as declared effective by the SEC on September 15, 2022 (SEC File Number 333-261989).

Previously filed as an

exhibit to Form 8-K/A as filed with the SEC on September 20, 2022.

Previously filed as an

exhibit to Form 10-Q as filed with the SEC on May 10, 2023.

Previously filed as an

exhibit to Form 10-Q as filed with the SEC on August 10, 2023.

Previously filed as an

exhibit to Form S-1 as declared effective by the SEC on June 27, 2024 (SEC File Number 333-279684).

filed as an exhibit to Form 8-K as filed with the SEC on July 3, 2024.

filed as an Exhibit to Form 8-K as filed with the SEC on September 19, 2024.

Filed as an exhibit to

this Form 10-Q.

to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 10-Q to be signed

on its behalf by the undersigned thereunto duly authorized on the 8th day of November, 2024.

Nexalin Technology, Inc.

Executive Officer

Compensation Recoupment Policy

Code of Ethics

Audit Committee Charter

Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Previously filed as an exhibit to Form S-1 as declared effective by the SEC on September 15, 2022 (SEC File Number 333-261989).

Previously filed as an exhibit to Form 8-K as filed with the SEC on September 20, 2022.

Previously filed as an exhibit to Form 8-K/A as filed with the SEC on September 20, 2022.

Previously filed as an exhibit to Form 10-Q as filed with the SEC on May 10, 2023.

Previously filed as an exhibit to Form 10-Q as filed with the SEC on August 10, 2023.

Previously filed as an exhibit to Form S-1/A as declared effective by the SEC on June 27, 2024 (SEC File Number 333-279684).

Previously filed as an exhibit to Form 8-K as filed with the SEC on July 3, 2024.

Previously filed as an exhibit to Form 8-K as filed with the SEC on September 19, 2024.

Previously filed as an exhibit to Form S-1/A as filed with the SEC on January 30, 2025 (SEC File Number 333-283960).

Previously filed as an exhibit to Form 10-K/A as filed with the SEC on April 15, 2025.

Filed as an exhibit to Form S-3 as declared effective by the SEC on April 29, 2025 (SEC File No.

Previously filed as an exhibit to Form 8-K as filed with the SEC on May 6, 2025.

Filed as an exhibit to this Form 10-Q.

Pursuant to the requirements of the Securities

Exchange Act of 1934, the Registrant has duly caused this Report on Form 10-Q to be signed on its behalf by the undersigned thereunto

duly authorized on the 13th day of May, 2025.

NEXALIN TECHNOLOGY, INC.

/s/ Mark White

Chief Executive Officer

Principal Executive Officer

Principal Financial Officer

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information